Treatment concerns for psychiatric symptoms in patients with COVID-19 with or without psychiatric disorders

Many psychiatric patients have been infected with COVID-19, and patients with COVID-19 may develop psychiatric symptoms after treatment with antiviral drugs. Given the tolerability and minimal P450 interactions, antidepressants (i.e., citalopram, escitalopram etc.), antipsychotics (i.e., olanzapine)...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Kai, Zhou, Xiaoqin, Liu, Huanzhong, Hashimoto, Kenji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2020
Materias:
Editorial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7190394/
https://www.ncbi.nlm.nih.gov/pubmed/32270760
http://dx.doi.org/10.1192/bjp.2020.84

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7190394/
https://www.ncbi.nlm.nih.gov/pubmed/32270760
http://dx.doi.org/10.1192/bjp.2020.84

Ejemplares similares